Premarket Analyst Action - Healthcare

Odonate Therapeutics (Pending:ODT) initiated with Buy rating and $40 (60% upside) price target by Jefferies. Initiated with Outperform rating by Cowen and Company.

Denali Therapeutics (Pending:DNLI) initiated with Overweight rating with a $24 (53% upside) price target by JPMorgan. Initiated with Neutral rating and $19 (21% upside) by Goldman Sachs. Initiated with Overweight rating by Morgan Stanley.

Haemonetics (NYSE:HAE) upgraded to Overweight by Morgan Stanley.

Globus Medical (NYSE:GMED) upgraded to Overweight by Morgan Stanley.

Incyte (NASDAQ:INCY) upgraded to Outperform by RBC Capital Markets. Shares up 1% premarket on light volume.

READ FULL ARTICLE HERE